Geneos Wealth Management’s EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF XOVR Stock Holding History

Geneos Wealth Management’s Portfolio XOVR Stock Details XOVR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.2K	Buy	+865	New	+$16.5K	﹤0.01%	1837

Other funds holding XOVR

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

AGM

Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BCM

Bluefin Capital Management New York $399M AUM 24.96% 1-Year Est. Return

Geneos Wealth Management's XOVR Position: Q2 2026 in Review

Geneos Wealth Management opened a new position in EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF (XOVR) in Q2 2026: 865 shares worth $18.2K. The stake represents ﹤0.01% of the portfolio and ranks #1837 among its holdings.

234 funds tracked by Wall St. Rank hold XOVR as of Q2 2026.

Geneos Wealth Management held 865 shares of EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF worth $18.2K as of Q2 2026.
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF was a new Geneos Wealth Management position in Q2 2026.
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1837 holding.
234 funds tracked by Wall St. Rank held EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.